Articles
-
Jun 27, 2024 |
bmjopenrespres.bmj.com | Toby Maher |Michael Kreuter |David Lederer |Kevin Brown
Interstitial lung disease Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2) Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service.
-
Mar 8, 2024 |
l8r.it | David Lederer
If you’ve ever walked by a rally held by Students for Justice in Palestine on campus over the past couple months, you may have noticed that, amid a sea of keffiyehs, masks, and watermelon designs, there is always that one counterprotester with an Israeli flag and a megaphone. That guy is me. In fact, I show up with my twin so often to challenge what seems to be pro-Hamas—not pro-Palestinian—rhetoric that the crowd knows who we are.
-
Mar 8, 2024 |
columbiaspectator.com | David Lederer
If you’ve ever walked by a rally held by Students for Justice in Palestine on campus over the past couple months, you may have noticed that, amid a sea of keffiyehs, masks, and watermelon designs, there is always that one counterprotester with an Israeli flag and a megaphone. That guy is me. In fact, I show up with my twin so often to challenge what seems to be pro-Hamas—not pro-Palestinian—rhetoric that the crowd knows who we are.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →